WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 14'3201 Infant (under 12 months) mortality rate: 722
GDP / capita (US$): 33'7201 Child (under 5 years) mortality rate: 1002

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 757  736  716  696  677  518  374  221 
Births 27  26  26  26  25  21  18 
Surviving infants 24  24  24  23  23  18  15 
Pop. less than 5 years 115  113  110  107  104  85  69  30 
Pop. less than 15 years 294  288  281  274  268  221  141  97 
Female 15-49 years 178  174  169  165  161  119  90  44 

Number of reported case

(Click for retrospective incidence data for Equatorial Guinea)
Diphtheria
Japanese encephalitis
Measles 321  1'190  78  32 
Mumps
Pertussis 67 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Equatorial Guinea)
Vaccine year result method % card seen                                                
BCG 2010  71  DHS   37  51  53  53  58  68  34 
DTP1 2010  59  DHS   37  47  54  42  59  99*  39 
DTP3 2010  41  DHS   37  24  41  54  44  74  32 
HepB_BD         
HepB3 2010  42  DHS   37 
Hib3 2010  42  DHS   37 
JapEnc         
MCV 2010  44  DHS   37  41  34  50  51  77  19 
MCV2         
PCV1         
PCV3         
Pol3 2010  34  DHS   37  40  40  53  39  68  32 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  63  DHS   37  31  30  64  54  57  30 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Equatorial Guinea)
BCG 71  73  73  71  71  73  94 
DTP1 55  62  65  59  60  64  96 
DTP3 20  33  44  43  34  77 
HepB3
HepB_BD
Hib3
MCV 42  35  51  51  51  51  88 
MCV2
PAB 75  75  75  75  75  61  58 
PCV3
Pol3 30  30  39  59  57  41  75 
Rota_last
YFV

Number of districts in the country 18  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 6
From 50 to 79% 11
Less than 50% 83
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 15 months; Yes
IPV From October 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; 15 months; Yes
TT +1, +2, +6 months; +1, +2 years; Yes pregnant women
VitaminA 6, 12 months; No

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2009-2013  2009-2013  2009-2013  2009-2013  2009-2013  NA   
Nº of districts with microplans that include activities to raise immunization coverage number 18  16  18   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 18  18  18  18  18  18  18 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 17  22  33 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 22  17   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No    No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  59  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.